Standout Papers
Citation Impact
Citing Papers
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Changes in the Expression of Junctional and Nonjunctional Complex Component Genes When Inter‐Sertoli Tight Junctions Are Formed In Vitro
2000
An extensive phenotypic characterization of the hTNFα transgenic mice
2007 StandoutNobel
Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI
2010
Retroviral superinfection resistance
2005
Improved Virological Outcomes in British Columbia Concomitant with Decreasing Incidence of HIV Type 1 Drug Resistance Detection
2009
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Regulation of Sertoli cell IL-1 and IL-6 production in vitro
1997
Use of ursodeoxycholic acid in liver diseases
2001
Combination of interferon and ribavirin in chronic hepatitis C: Re-treatment of nonresponders to interferon
2001
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Clinical and Biological Evolution of HIV-1 Seroconverters in Abidjan, Côte d'Ivoire, 1997–2000
2002 StandoutNobel
Combination of HIV‐1–Specific CD4 Th1 Cell Responses and IgG2 Antibodies Is the Best Predictor for Persistence of Long‐Term Nonprogression
2005
European Resuscitation Council Guidelines for Resuscitation 2010 Section 2. Adult basic life support and use of automated external defibrillators
2010 Standout
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivo
2008
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
2005 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection
1998
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Regulation of α2-Macroglobulin Expression in Rat Sertoli Cells and Hepatocytes by Germ Cells In Vitro1
1998
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Defensins: antimicrobial peptides of innate immunity
2003 Standout
Antibodies to the nef Protein and to nef Peptides in HIV-1—Infected Seronegative Individuals
1989 StandoutNobel
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy
2003
Text Message Intervention Designs to Promote Adherence to Antiretroviral Therapy (ART): A Meta-Analysis of Randomized Controlled Trials
2014
Molecular assays for monitoring HIV infection and antiretroviral therapy
2007
Phylogenetic Analysis of SIV and STLV Type I in Mandrills ( Mandrillus sphinx ): Indications That Intracolony Transmissions Are Predominantly the Result of Male-to-Male Aggressive Contacts
1998 StandoutNobel
Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards
2012 StandoutNobel
New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir
2009
Inflammatory Bowel Disease
2009 Standout
Identification, Isolation, and Characterization of a 41-Kilodalton Protein from Rat Germ Cell-Conditioned Medium Exhibiting Concentration-Dependent Dual Biological Activities1
1997
Interferons and interferon-induced antiviral proteins in the testis
1998
The Impact of mHealth Interventions: Systematic Review of Systematic Reviews
2018 Standout
Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature
2006
Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection
2003
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Molecular Methods and Platforms for Infectious Diseases Testing
2011
Use of therapeutic drug monitoring in HIV disease
2008
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis
1997
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells
2005
The effects of an in utero exposure to 2,3,7,8‐tetrachloro‐dibenzo‐p‐dioxin on male reproductive function: identification of Ccl5 as a potential marker
2010
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
2011 StandoutNobel
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
2012 Standout
TREATMENT OF HCV
1997
Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel
2008
A multicenter, randomized, controlled clinical trial of interferon alfacon-1 in comparison with lymphoblastoid interferon-alpha in patients with high-titer chronic hepatitis C virus infection
2002
Long‐Term Trends of HIV Type 1 Drug Resistance Prevalence among Antiretroviral Treatment–Experienced Patients in Switzerland
2009
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
2005
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey
2007
Glutathione synthesis
2012 Standout
Switch from Enfuvirtide to Raltegravir in Virologically Suppressed Multidrug‐Resistant HIV‐1–Infected Patients: A Randomized Open‐Label Trial
2009
Expression of Antimicrobial Defensins in the Male Reproductive Tract of Rats, Mice, and Humans1
2003
Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Critical Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor Assay
2009
JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
2008
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Predicting human immunodeficiency virus inhibitors using multi-dimensional Bayesian network classifiers
2013
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study
2009
Rat testicular myotubularin, a protein tyrosine phosphatase expressed by Sertoli and germ cells, is a potential marker for studying cell-cell interactions in the rat testis
2000
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France
2011
Interactions of Proteases and Protease Inhibitors in Sertoli‐Germ Cell Cocultures Preceding the Formation of Specialized Sertoli‐Germ Cell JunctionsIn Vitro
1997
Interpreting resistance data for HIV-1 therapy management--know the limitations.
2006
Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils
2015 StandoutNobel
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells
2005
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infection
1990 StandoutNobel
TNF-α and IFN-γ Regulate Expression and Function of the Fas System in the Seminiferous Epithelium
2000
Infection and AIDS in Adult Macaques After Nontraumatic Oral Exposure to Cell-Free SIV
1996 Science
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Point-of-Care Diagnostics for Global Health
2008 Standout
Genetically Related Human Immunodeficiency Virus Type 1 in Three Adults of a Family with No Identified Risk Factor for Intrafamilial Transmission
1998 StandoutNobel
Towards an HIV cure: a global scientific strategy
2012
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis
2004 Standout
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
The Testicular Antiviral Defense System: Localization, Expression, and Regulation of 2′5′ Oligoadenylate Synthetase, Double-Stranded RNA-activated Protein Kinase, and Mx Proteins in the Rat Seminiferous Tubule
1997
A Review on Multi-Label Learning Algorithms
2013 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
The Simian Immunodeficiency Virus ΔnefVaccine, after Application to the Tonsils of Rhesus Macaques, Replicates Primarily within CD4+T Cells and Elicits a Local Perforin-Positive CD8+T-Cell Response
2002 StandoutNobel
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Attitudes of BCLS instructors about mouth-to-mouth resuscitation during the AIDS epidemic
1990
Expression of Interferons-α and -γ in Testicular Interstitial Tissue and Spermatogonia of the Rat*
1998
Works of Annick Ruffault being referenced
HIV RNA and HIV DNA in Peripheral Blood Mononuclear Cells Are Consistent Markers for Estimating Viral Load in Patients Undergoing Long-Term Potent Treatment
2000
Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo
2008
The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir–ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients
2007
Human Immunodeficiency Virus Infects Human Seminal Vesicles in Vitro and in Vivo
2011
Prevalence of HIV-1 Drug Resistance in Treated Patients
2007
Susceptibility of Human Testis to Human Immunodeficiency Virus-1 Infection in Situ and in Vitro
2006
JC Virus Genotypes in France: Molecular Epidemiology and Potential Significance for Progressive Multifocal Leukoencephalopathy
2001
Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France
2003
Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance
2005
Prevalence of JC Virus Viraemia in HIV-Infected Patients with or Without Neurological Disorders: A Prospective Study
1998
Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: results from a controlled randomized trial in 80 patients.
1995
Evaluation of the Roche Cobas TaqMan and Abbott RealTime Extraction-Quantification Systems for HIV-1 Subtypes
2007
Genotypic and Phenotypic Resistance Patterns of Human Immunodeficiency Virus Type 1 Variants with Insertions or Deletions in the Reverse Transcriptase (RT): Multicenter Study of Patients Treated with RT Inhibitors
2001
Zidovudine Resensitization and Dual HIV-1 Resistance to Zidovudine and Lamivudine in the Delta Lamivudine Roll-Over Study
1999
TRANSMISSIBILITY OF HUMAN IMMUNODEFICIENCY VIRUS IN HAEMOPHILIC AND NON-HAEMOPHILIC CHILDREN LIVING IN A PRIVATE SCHOOL IN FRANCE
1986 StandoutNobel
The Prognostic Value of Plasma Viremia in HIV-Infected Patients Under AZT Treatment
1995
Production of the Chemokines Monocyte Chemotactic Protein-1, Regulated on Activation Normal T Cell Expressed and Secreted Protein, Growth-Related Oncogene, and Interferon-γ-Inducible Protein-10 Is Induced by the Sendai Virus in Human and Rat Testicular Cells
2002
Tipranavir-Ritonavir Genotypic Resistance Score in Protease Inhibitor-Experienced Patients
2008
HIV-1 group M superinfection in an HIV-1 group O-infected patient.
2004
Interferon and ursodeoxycholic acid combined therapy in the treatmet of chronic viral C hepatitis: Results from a controlled randomized trial in 80 patients
1995
Interferon-alpha and -gamma expression in the rat testis.
1995
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study
2013